Ayanda
SIRIO Europe (operating as Ayanda) is a privately held B2B contract development and manufacturing organization (CDMO) that produces nutraceutical softgels, gummies, and proprietary delivery formats for brand customers in the nutraceutical, pharmaceutical, sports nutrition and beauty/wellness sectors globally.
- Company typePrivate
- Founded1993
- HeadquartersOslo, Norway
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What Ayanda does
SIRIO Europe (legally Sirio Europe GmbH & Co. KG, operating its German manufacturing facility under the Ayanda brand) is a privately held contract development and manufacturing organization (CDMO) that develops and produces nutraceutical and pharmaceutical dosage forms on behalf of brand customers. The company is headquartered at its primary European manufacturing site in Pritzwalk, Germany, with additional registered offices in Frankfurt am Main and production facilities in Shantou and Anhui (China) and the USA; the broader SIRIO Group employs more than 2,700 people across China, Germany, the USA, Singapore and Thailand. Its customer base consists of nutraceutical brands, pharmaceutical companies, sports-nutrition brands and beauty/wellness labels that buy contract-manufactured products and private-label concepts.
The product portfolio is anchored on four core delivery formats — gummies (including high-strength XtraGummies™), softgels (gelatin and plant-based Plantegrity®), LifeChews™ chewable jelly tablets and FizzyBits™ instant dissolving tablets — supported by the Snowmelt™ direct-to-mouth powder format and trademarked sub-brands including EnteriClear®, HydraPearls™ and Aeion™. Proprietary technology is a key differentiator: Plantegrity® covers four patented plant-based shell variants including an enteric gellan-gum shell; LifeChews™ is clinically validated for 161% higher plasma DHA concentration versus control; and XtraGummies™ enables up to 1.5g of creatine per gummy. Branded concept platforms bundle these formats into ready-to-launch ranges (Aeion™ longevity, X Mg magnesium, Hydration Reinvented), giving brand customers a faster path to market than custom formulation alone.
The business model is B2B contract manufacturing with quote-based pricing, minimum order quantities starting at 500,000 units and multi-year contracts; the go-to-market is enterprise field sales organised by region (DACH, South Europe, EMEA, Key Accounts, Retail/Pharmacy Chains), supported by major trade-show presence at Vitafoods Europe and CPHI, proprietary Innovation for the Future Summits, and thought-leadership content (podcast, webinars, downloadable catalogues). Revenue is not publicly disclosed. Quality and compliance are positioned as a primary asset: SIRIO holds GMP, BRCGS, IFS, FDA, MSC Chain of Custody, Organic, Friend of the Sea and ISO 14001/50001/45001/14064 certifications, plus EcoVadis Silver with dual-facility ranking in the global top 15%, making it an approved supplier for regulated retail and pharmacy channels in both the EU and the US.
Ayanda firmographics
Firmographics- Name
- Ayanda
- Legal name
- Sirio Europe GmbH & Co. KG
- Website
- https://ayanda.com
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- SIRIO Europe (operating as Ayanda) is a privately held B2B contract development and manufacturing organization (CDMO) that produces nutraceutical softgels, gummies, and proprietary delivery formats for brand customers in the nutraceutical, pharmaceutical, sports nutrition and beauty/wellness sectors globally.
- Ownership category
- akta.pro rank
Where Ayanda is headquartered
LocationHeadquarters
- HQ city
- Oslo
- HQ country
- Norway
- HQ region
- Europe
Offices5 records
Markets served
Ayanda business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Contract Development and Manufacturing Services: Full-service CDMO providing end-to-end development, manufacturing, and packaging services for dietary supplements and pharmaceutical softgels. Revenue generated through service fees, manufacturing contracts, and project-based development work for B2B clients.
- Private Label Manufacturing: Private label production of ready-to-launch formulations including gummies, softgels, and innovative delivery formats. Clients can select from pre-developed concepts or commission custom formulations.
- Product Sales (Bulk Manufacturing): Bulk manufacturing of supplement products for B2B customers including nutraceutical companies, pharmaceutical firms, and brand owners. Minimum order quantities starting at 500,000 units for typical production runs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Multi-year contract | Quote-based pricing for bulk manufacturing |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Ayanda product offering
Product offeringCore offering
SIRIO Europe (operating under the Ayanda brand) is a B2B Contract Development and Manufacturing Organization (CDMO) that develops, manufactures, and packages dietary supplement dosage forms for nutraceutical and pharmaceutical brand clients. Its core deliverables include gummies, softgels (gelatine and plant-based), LifeChews™ jelly tablets, and FizzyBits™ instant fizzy tablets, supported by proprietary technologies such as Plantegrity® and EnteriClear®, plus ready-to-launch concept platforms spanning beauty, sports, women's health, hydration, magnesium, and longevity. Services span R&D, manufacturing, quality management, packaging, and private label production with minimum order quantities of 500,000+ units.
Product overview
Ayanda operates as a Contract Development and Manufacturing Organization (CDMO) providing end-to-end services for nutraceutical and pharmaceutical dosage forms. The product portfolio centers on four core delivery formats: Gummies (including XtraGummies™ high-strength variants), Softgels (gelatine and plant-based Plantegrity®), LifeChews™ jelly tablets, and FizzyBits™ instant fizzy tabs. These formats are supported by specialized technology platforms including Aeion™ longevity platform, X Mg magnesium platform, and Hydration Reinvented platform. Key sub-brands include EnteriClear® enteric technology, HydraPearls™ skin hydration softgels, and Snowmelt™ DTM powder. Services include development, manufacturing, quality management, and private label manufacturing across facilities in Europe, USA, and China.
Differentiator
Problem solved
Functional benefit
Brands
- Plantegrity®: Patented plant-based softgel technology using carrageenan or gellan gum for vegan-friendly capsule solutions.
- XtraGummies™
- FizzyBits™
- LifeChews™
- Aeion™
- Snowmelt™
- HydraPearls™
- EnteriClear®
- Aeion™ NAD+ Energy
Products and services
- Gummies
Quantifiable outcome
- 198% improvement in bioavailability with LifeChews™ vs control (161% higher blood plasma DHA concentration)
- +5 more outcomes
Companies that use Ayanda
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Ayanda technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Ayanda partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- ADMcoreADM (Archer Daniels Midland) presented advances in probiotic and postbiotic ingredient science at the 7th Innovation for the Future Summit in Amsterdam. SIRIO collaborated with ADM on ingredient innovation and science-backed formulation approaches for the nutraceutical market.
- KD PharmacoreKD Pharma presented omega-3 innovation topics including 'Beyond Fish Oil: What's Next in Omega-3 Innovation' at SIRIO's Innovation for the Future Summit. Represents key ingredient supplier partnership for omega-3 formulations.
- Aker BioMarinecoreAker BioMarine participated as speaker at SIRIO's Innovation for the Future Summit discussing omega-3 alternatives and solutions. Key supplier of premium, science-backed omega-3 products for SIRIO formulations.
- Zooca® (Calanus Company)minorZooca® Calanus® Oil presented as innovative marine lipid ingredient at SIRIO's Innovation for the Future Summit. Represents sustainable omega-3 alternative ingredient sourced from Calanus finmarchicus.
- Balchem CorporationcoreBalchem presented 'Performance by design: The benefits behind sports ingredients' at Innovation for the Future Summit Berlin. Partnership focused on ingredient science and sports nutrition formulations.
- EHPM (European Federation of Associations of Health Product Manufacturers)coreEHPM Director-General Livia Menichetti presented on key regulatory developments impacting supplements at the Innovation for the Future Summit Amsterdam. Partnership for regulatory intelligence and industry advocacy.
- Innova Market InsightscoreInnova Market Insights provided dietary supplements market and consumer trends analysis at both Amsterdam and Berlin Innovation Summits. Partnership for market intelligence and trend forecasting.
- Novasol (Aquanova)coreAquanova/Novasol presented on bioavailability and why it determines performance at the Berlin Innovation Summit. Provider of NovaSOL® colloidal ingredient technology for enhanced absorption.
- GivaudanminorGivaudan conducted flavor training sessions on evaluating samples at the Amsterdam Innovation Summit. Partnership for flavor development and sensory optimization of SIRIO formulations.
- Bureau VeritascoreThird-party verification partner for carbon inventories and emissions data across all manufacturing sites. Provides independent verification of sustainability metrics under ISO 14064:2018.
- SIRIO Institute on AgeingcoreResearch collaboration for longevity platform development. Aeion™ longevity platform developed in collaboration with the SIRIO Institute on Ageing and renowned longevity researchers.
Scale indicators10 records
Recent moves7 records
Expansion highlights6 records
Ayanda competitors and assessment
Company assessmentDirect peers
- Aenova Group: Aenova is one of Europe's largest pharmaceutical and nutraceutical CDMOs, headquartered in Germany with a comparable mix of softgel, tablet, and packaging services serving brand customers globally — the closest geographic and product-model peer to SIRIO Europe/Ayanda.
- Procaps Group: Procaps is an integrated CDMO and branded nutraceutical company based in Latin America offering softgel, gummy, and powder contract manufacturing with proprietary technologies — a closely aligned nutraceutical CDMO peer with similar proprietary delivery platform strategy.
- Hermes Arzneimittel: Hermes is a German pharmaceutical manufacturer with CDMO services in effervescents, tablets, and specialty oral dosage forms serving European and international brands — a regional direct peer in German pharma/nutra contract manufacturing.
Broad incumbents
- Catalent: Catalent is a global pharma and consumer health CDMO offering softgel (formerly Accucaps), gummy, and oral dose technologies with facilities worldwide, including Europe. It overlaps with SIRIO Europe in nutraceutical softgels but operates at much larger scale and across a broader pharma portfolio.
- Adare Pharmaceuticals: Adare Pharma Solutions is a US-based CDMO with technology platforms for taste-masking, modified release, and oral dosage forms serving pharma and consumer health customers — a broader incumbent with overlapping CDMO services and proprietary technology focus.
- Patheon (Thermo Fisher Scientific): Patheon, part of Thermo Fisher, is a global pharma CDMO with broad oral solid and softgel capabilities serving brand and generic customers — a broad incumbent competing with SIRIO Europe for premium contract manufacturing relationships.
- PCI Pharma Services: PCI Pharma Services is a global pharma CDMO providing clinical and commercial manufacturing, packaging, and supply chain services — a broader incumbent with adjacent CDMO capabilities serving regulated pharma and consumer health customers.
Regional players
- Bioplus Life Sciences: Bioplus is a Korean pharma CDMO offering oral solid, sterile injectable, and specialty manufacturing — a regional peer in Asian CDMO services with comparable technology platform focus but operating in different geographies.
Emerging players
- AB Biotics: AB Biotics is a Spanish biotech CDMO specializing in probiotics, synbiotics, and microbiome-based formulations with proprietary strain technology — a niche emerging player overlapping with SIRIO Europe's specialized ingredient and delivery format innovation.
Others
- Balchem Corporation: Balchem is a US ingredient supplier and contract manufacturer for human nutrition and pharma with mineral chelates and encapsulation expertise — an ecosystem partner (co-presenter at SIRIO's Innovation for the Future Summit) that competes for some CDMO business at the ingredient/formulation tier.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Ayanda social profiles
Digital presenceAyanda compliance and trust
Trust signalCompliance13 records
Ayanda financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ayanda leadership team
Management profileNumber of profiles
Profiles7 records
Ayanda subsidiaries and ownership
Company hierarchySubsidiaries2 records
Ayanda funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ayanda M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ayanda
What does Ayanda do?
SIRIO Europe (operating under the Ayanda brand) is a B2B Contract Development and Manufacturing Organization (CDMO) that develops, manufactures, and packages dietary supplement dosage forms for nutraceutical and pharmaceutical brand clients. Its core deliverables include gummies, softgels (gelatine and plant-based), LifeChews™ jelly tablets, and FizzyBits™ instant fizzy tablets, supported by proprietary technologies such as Plantegrity® and EnteriClear®, plus ready-to-launch concept platforms spanning beauty, sports, women's health, hydration, magnesium, and longevity. Services span R&D, manufacturing, quality management, packaging, and private label production with minimum order quantities of 500,000+ units.
Is Ayanda a public or private company?
Ayanda is a private company. It is classified as unknown and is currently operating.
When was Ayanda founded?
Ayanda was founded in 1993. It employs 501 to 1,000 people.
Where is Ayanda based?
Ayanda is headquartered in Oslo, Norway, in the Europe region.
How does Ayanda make money?
Three revenue lines are on record. Contract Development and Manufacturing Services are the primary driver. The others are private Label Manufacturing and product Sales (Bulk Manufacturing).
Who are Ayanda's main competitors?
Direct peers on record are Aenova Group, Procaps Group and Hermes Arzneimittel. Broad incumbents are Catalent, Adare Pharmaceuticals, Patheon (Thermo Fisher Scientific) and PCI Pharma Services. Bioplus Life Sciences is listed as a regional player. AB Biotics is listed as an emerging player. Balchem Corporation is listed as an others.
Does Ayanda have an API?
No public API is recorded for Ayanda.